Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 57,526	$ 34,522
Marketable securities	177,161	240,736
Accounts receivable (net of allowance of $4,587 as of December 31, 2023)	20,473	24,790
Prepaid expenses	9,067	14,520
Other current assets	13,774	20,403
Total current assets	278,001	334,971
Marketable securities	10,179	38,871
Accounts receivable	474	701
Property and equipment, net	117,589	132,103
Operating lease right-of-use assets	53,716	60,487
Restricted cash	2,030	2,030
Other assets	4,000	4,807
Total assets	465,989	573,970
Current liabilities
Accounts payable	22,798	22,786
Accrued expenses and other current liabilities	38,070	49,703
Deferred revenue	115	148
Operating lease liabilities	7,902	7,068
Liability related to sale of future royalties	34,309	50,567
Total current liabilities	103,194	130,272
Operating lease liabilities	74,131	82,222
Liability related to sale of future royalties	25,378	43,485
Other liabilities	3,635	6,249
Total liabilities	206,338	262,228
Commitments and contingencies (Note 8)
Stockholders’ equity
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at December 31, 2024 and 2023
Common stock; $0.0001 par value; 100,000 shares authorized at December 31, 2024 and 2023; 49,549 and 44,046 shares issued and outstanding at December 31, 2024 and 2023, respectively	5	4
Additional paid-in capital	1,192,536	1,021,214
Accumulated other comprehensive loss	(741)	(4,429)
Accumulated deficit	(932,149)	(705,047)
Total stockholders’ equity	259,651	311,742
Total liabilities and stockholders’ equity	$ 465,989	$ 573,970